Variation of 4 MV X-ray dose rate strongly impacts biological response both in vitro and in vivo.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
27 04 2020
Historique:
received: 05 12 2019
accepted: 10 04 2020
entrez: 29 4 2020
pubmed: 29 4 2020
medline: 15 12 2020
Statut: epublish

Résumé

Whereas an RBE > 1 is described for very low-energy X-ray beams (in the range of 25-50 kV), there is a consensus that the RBE of X-rays (from 0.1 to 3 MeV) is equal to 1, whatever the energy or dose rate of the beam. Comparisons of X-ray beam dose rates are scarce even though these beams are widely used in medical diagnosis or radiotherapy. By using two dose rates (0.63 and 2.5 Gy.min

Identifiants

pubmed: 32341396
doi: 10.1038/s41598-020-64067-4
pii: 10.1038/s41598-020-64067-4
pmc: PMC7184727
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7021

Références

Brewen, J. G. & Luippold, H. E. Radiation-induced human chromosome aberrations: in vitro dose rate studies. Mutat. Res. 12(3), 305–314 (1971).
pubmed: 5563945 doi: 10.1016/0027-5107(71)90018-2
Vaurijoux, A. et al. Automatic Dicentric Scoring a Real Option to Be Used in Biological Dosimetry. Radiat. Emerg. Med. 4(1), 16–21 (2015).
Fabry, L. Cytogenetic damage induced in human lymphocytes by low doses of 60Co gamma rays delivered at high and low dose rates. Acta Radiol. Oncol. 25(2), 143–146 (1986).
pubmed: 3012959 doi: 10.3109/02841868609136393
Scott, D. et al. Radiation-induced chromosome damage in human peripheral blood lymphocytes in vitro. II. RBE and dose-rate studies with 60Co gamma- and X-rays. Mutat. Res. 9(2), 225–237 (1970).
pubmed: 5413680 doi: 10.1016/0027-5107(70)90061-8
Brehwens, K. et al. A new device to expose cells to changing dose rates of ionising radiation. Radiat. Prot. Dosimetry 148(3), 366–371 (2012).
pubmed: 21486830 doi: 10.1093/rpd/ncr092
Lasio, G. et al. Effect of varying dose-per-pulse and average dose rate in X-ray beam irradiation on cultured cell survival. Radiat. Env. Biophys. 53(4), 671–676 (2014).
doi: 10.1007/s00411-014-0565-2
Sarojini, S. et al. A combination of high dose rate (10X FFF/2400 MU/min/10 MV X-rays) and total low dose (0.5 Gy) induces a higher rate of apoptosis in melanoma cells in vitro and superior preservation of normal melanocytes. Melanoma Res. 25(5), 376–389 (2015).
pubmed: 26177150 pmcid: 4560269 doi: 10.1097/CMR.0000000000000174
Verbakel, W. F. et al. Comparable cell survival between high dose rate flattening filter free and conventional dose rate irradiation. Acta Oncol. 52(3), 652–657 (2013).
pubmed: 23126524 doi: 10.3109/0284186X.2012.737021
Brehwens, K. et al. Cytogenetic damage in cells exposed to ionizing radiation under conditions of a changing dose rate. Radiat. Res. 173(3), 283–289 (2010).
pubmed: 20199213 doi: 10.1667/RR2012.1
Joiner, M.C. & van der Kogel, A. Basic Clinical Radiobiology Fourth Edition. Taylor & Francis (2009).
Paganetti, H. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys. Med. Biol. 59(22), R419–72 (2014).
pubmed: 25361443 doi: 10.1088/0031-9155/59/22/R419
Valentin, J. Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (wR):ICRP Publication 92: Approved by the Commission in January 2003. Ann. ICRP. 33(4), 1–121 (2003).
doi: 10.1016/S0146-6453(03)00024-1
Gomolka, M. et al. Measurement of the initial levels of DNA damage in human lymphocytes induced by 29 kV X rays (mammography X rays) relative to 220 kV X rays and gamma rays. Radiat. Res. 163(5), 510–519 (2005).
pubmed: 15850412 doi: 10.1667/RR3343
Hill, M. A. The variation in biological effectiveness of X-rays and gamma rays with energy. Radiat. Prot. Dosimetry 112(4), 471–481 (2004).
pubmed: 15623881 doi: 10.1093/rpd/nch091
Kashino, G. et al. Evidence for induction of DNA double strand breaks in the bystander response to targeted soft X-rays in CHO cells. Mutat. Res. 556(1-2), 209–215 (2004).
pubmed: 15491649 doi: 10.1016/j.mrfmmm.2004.08.009
Slonina, D. et al. Induction of micronuclei in human fibroblasts and keratinocytes by 25 kV x-rays. Radiat. Env. Biophys. 42(1), 55–61 (2003).
doi: 10.1007/s00411-003-0177-8
Kaderka, R. et al. Out-of-field dose measurements in a water phantom using different radiotherapy modalities. Phys. Med. Biol. 57(16), 5059–5074 (2012).
pubmed: 22836598 doi: 10.1088/0031-9155/57/16/5059
Yoon, J. et al. Measurement and modeling of out-of-field doses from various advanced post-mastectomy radiotherapy techniques. Phys. Med. Biol. 62(23), 9039–9053 (2017).
pubmed: 29048329 pmcid: 5724526 doi: 10.1088/1361-6560/aa94b5
Jagetic, L. J. & Newhauser, W. D. A simple and fast physics-based analytical method to calculate therapeutic and stray doses from external beam, megavoltage x-ray therapy. Phys. Med. Biol. 60(12), 4753–4775 (2015).
pubmed: 26040833 doi: 10.1088/0031-9155/60/12/4753
Hall, E. J. & Brenner, D. J. The dose-rate effect revisited: radiobiological considerations of importance in radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 21(6), 1403–1414 (1991).
pubmed: 1938548 doi: 10.1016/0360-3016(91)90314-T
Jensen, M. H. et al. Late changes following single dose roentgen irradiation of rat small intestine. Acta Radiol. Oncol. 22(4), 299–303 (1983).
pubmed: 6316752 doi: 10.3109/02841868309134045
Dos Santos, M. et al. Importance of dosimetry protocol for cell irradiation on a low X-rays facility and consequences for the biological response. Int J Radiat Biol. 1–29 (2018).
Korpela, E. & Liu, S. K. Endothelial perturbations and therapeutic strategies in normal tissue radiation damage. Radiat. Oncol. 9, 266 (2014).
pubmed: 25518850 pmcid: 4279961 doi: 10.1186/s13014-014-0266-7
Guipaud, O. et al. The importance of the vascular endothelial barrier in the immune-inflammatory response induced by radiotherapy. Br. J. Radiol., 20170762 (2018).
Krishnan, E. C. et al. Dose-dependent radiation effect on microvasculature and repair. J. Natl Cancer Inst. 79(6), 1321–1325 (1987).
pubmed: 3480383
Park, K. R. et al. Mast Cells Contribute to Radiation-Induced Vascular Hyperpermeability. Radiat. Res. 185(2), 182–189 (2016).
pubmed: 26771172 pmcid: 4761451 doi: 10.1667/RR14190.1
Oktaria, S. et al. In vitro investigation of the dose-rate effect on the biological effectiveness of megavoltage X-ray radiation doses. Appl. Radiat. Isot. 128, 114–119 (2017).
pubmed: 28709028 doi: 10.1016/j.apradiso.2017.07.008
Terashima, S. et al. Impact of time interval and dose rate on cell survival following low-dose fractionated exposures. J. Radiat. Res. 58(6), 782–790 (2017).
pubmed: 28595296 pmcid: 5710595 doi: 10.1093/jrr/rrx025
Karan, T. et al. SU-E-T-01: Applications of 6MV FFF Photon Beams in Optimizing Radiobiological Response for Respiratory-Gated Liver SBRT. Med. Phys. 39(6Part9), 3702 (2012).
pubmed: 28519033 doi: 10.1118/1.4735055
Lohse, I. et al. Effect of high dose per pulse flattening filter-free beams on cancer cell survival. Radiother. Oncol. 101(1), 226–232 (2011).
pubmed: 21733592 doi: 10.1016/j.radonc.2011.05.072
Sorensen, B. S. et al. Dependence of cell survival on instantaneous dose rate of a linear accelerator. Radiother. Oncol. 101(1), 223–225 (2011).
pubmed: 21737168 doi: 10.1016/j.radonc.2011.06.018
Puck, T. T. & Marcus, P. I. Action of x-rays on mammalian cells. J. Exp. Med. 103(5), 653–666 (1956).
pubmed: 13319584 pmcid: 2136626 doi: 10.1084/jem.103.5.653
Franken, N. A. et al. Clonogenic assay of cells in vitro. Nat. Protoc. 1(5), 2315–2319 (2006).
pubmed: 17406473 doi: 10.1038/nprot.2006.339
Mori, R. et al. Estimation of the radiation-induced DNA double-strand breaks number by considering cell cycle and absorbed dose per cell nucleus. J. Radiat. Res. 59(3), 253–260 (2018).
pubmed: 29800455 pmcid: 5967466 doi: 10.1093/jrr/rrx097
Hernandez-Segura, A., Nehme, J. & Demaria, M. Hallmarks of Cellular Senescence. Trends Cell Biol. 28(6), 436–453 (2018).
doi: 10.1016/j.tcb.2018.02.001 pubmed: 29477613
Campisi, J. & d’Adda di Fagagna, F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8(9), 729–740 (2007).
pubmed: 17667954 doi: 10.1038/nrm2233
Di Leonardo, A. et al. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes. Dev. 8(21), 2540–2551 (1994).
pubmed: 7958916 doi: 10.1101/gad.8.21.2540
Debacq-Chainiaux, F. et al. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat. Protoc. 4(12), 1798–1806 (2009).
doi: 10.1038/nprot.2009.191 pubmed: 20010931
Itahana, K., Campisi, J. & Dimri, G. P. Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol. Biol. 371, 21–31 (2007).
pubmed: 17634571 doi: 10.1007/978-1-59745-361-5_3
Burton, D. G. & Krizhanovsky, V. Physiological and pathological consequences of cellular senescence. Cell Mol. Life Sci. 71(22), 4373–4386 (2014).
pubmed: 25080110 pmcid: 4207941 doi: 10.1007/s00018-014-1691-3
Abderrahmani, R. et al. Effects of pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 in radiation-induced intestinal injury. Int. J. Radiat. Oncol. Biol. Phys. 74(3), 942–948 (2009).
pubmed: 19480973 doi: 10.1016/j.ijrobp.2009.01.077
Abderrahmani, R. et al. PAI-1-dependent endothelial cell death determines severity of radiation-induced intestinal injury. PLoS One. 7(4), e35740 (2012).
pubmed: 22563394 pmcid: 3338537 doi: 10.1371/journal.pone.0035740
Koch, A. et al. Establishment of Early Endpoints in Mouse Total-Body Irradiation Model. PLoS One. 11(8), e0161079 (2016).
pubmed: 27579862 pmcid: 5007026 doi: 10.1371/journal.pone.0161079
Nunamaker, E. A. et al. Endpoint refinement for total body irradiation of C57BL/6 mice. Comp. Med. 63(1), 22–28 (2013).
pubmed: 23561934 pmcid: 3567373
Vriesendorp, H. M. et al. Survival after total body irradiation: effects of irradiation of exteriorized small intestine. Radiother. Oncol. 23(3), 160–169 (1992).
pubmed: 1533466 doi: 10.1016/0167-8140(92)90326-P
Rannou, E. et al. In vivo evidence for an endothelium-dependent mechanism in radiation-induced normal tissue injury. Sci. Rep. 5, 15738 (2015).
pubmed: 26510580 pmcid: 4625166 doi: 10.1038/srep15738
Blirando, K. et al. Mast cells are an essential component of human radiation proctitis and contribute to experimental colorectal damage in mice. Am. J. Pathol. 178(2), 640–651 (2011).
pubmed: 21281796 pmcid: 3069878 doi: 10.1016/j.ajpath.2010.10.003
Mintet, E. et al. Endothelial Hey2 deletion reduces endothelial-to-mesenchymal transition and mitigates radiation proctitis in mice. Sci. Rep. 7(1), 4933 (2017).
pubmed: 28694461 pmcid: 5503994 doi: 10.1038/s41598-017-05389-8
Paget, V. et al. Multiparametric radiobiological assays show that variation of X-ray energy strongly impacts relative biological effectiveness: comparison between 220 kV and 4 MV. Sci. Rep. 9(1), 14328 (2019).
pubmed: 31586152 pmcid: 6778087 doi: 10.1038/s41598-019-50908-4
Nunez, R. DNA measurement and cell cycle analysis by flow cytometry. Curr. Issues Mol. Biol. 3(3), 67–70 (2001).
pubmed: 11488413
Shuryak, I., Sun, Y. & Balajee, A. S. Advantages of Binomial Likelihood Maximization for Analyzing and Modeling Cell Survival Curves. Radiat. Res. 185(3), 246–256 (2016).
pubmed: 26930380 doi: 10.1667/RR14195.1
Good, P. I. Permutation, Parametric, and Bootstrap Tests of Hypotheses. 3 ed. Springer New York. 316 (2005).
Aitchison, J. The Statistical Analysis of Compositional Data. J. R. Stat. Society: Ser. B 44(2), 139–160 (1982).
Development Core Team, R., R: A Language and Environment for Statistical Computing. Vol. 1. (2011).
Ramsay, J. O. & Silverman, B. W. Functional data analysis. Springer (1997).
Karhunen, K. Uber lineare Methoden in der Wahrscheinlichkeitsrechnung. [Kirjapaino oy. sana]. Helsinki. (1947).

Auteurs

M Ben Kacem (M)

Institute for Radiological Protection and Nuclear Safety (IRSN), Department of RAdiobiology and Regenerative Medicine (SERAMED), Laboratory of Medical Radiobiology (LRMed), Fontenay-aux-Roses, 92260, France.

M A Benadjaoud (MA)

Institute for Radiological Protection and Nuclear Safety (IRSN), Department of Radiobiology and Regenerative Medicine (SERAMED), Fontenay-aux-Roses, France.

M Dos Santos (M)

Institute for Radiological Protection and Nuclear Safety (IRSN), Department of Radiobiology and Regenerative Medicine (SERAMED), Laboratory of Radiobiology of Accidental Exposures (LRAcc), Fontenay-aux-Roses, France.

F Soysouvanh (F)

Institute for Radiological Protection and Nuclear Safety (IRSN), Department of RAdiobiology and Regenerative Medicine (SERAMED), Laboratory of Medical Radiobiology (LRMed), Fontenay-aux-Roses, 92260, France.

V Buard (V)

Institute for Radiological Protection and Nuclear Safety (IRSN), Department of RAdiobiology and Regenerative Medicine (SERAMED), Laboratory of Medical Radiobiology (LRMed), Fontenay-aux-Roses, 92260, France.

G Tarlet (G)

Institute for Radiological Protection and Nuclear Safety (IRSN), Department of RAdiobiology and Regenerative Medicine (SERAMED), Laboratory of Medical Radiobiology (LRMed), Fontenay-aux-Roses, 92260, France.

B Le Guen (B)

Electricité de France, Cap Ampère, Saint-Denis, France.

A François (A)

Institute for Radiological Protection and Nuclear Safety (IRSN), Department of RAdiobiology and Regenerative Medicine (SERAMED), Laboratory of Medical Radiobiology (LRMed), Fontenay-aux-Roses, 92260, France.

O Guipaud (O)

Institute for Radiological Protection and Nuclear Safety (IRSN), Department of RAdiobiology and Regenerative Medicine (SERAMED), Laboratory of Medical Radiobiology (LRMed), Fontenay-aux-Roses, 92260, France.

F Milliat (F)

Institute for Radiological Protection and Nuclear Safety (IRSN), Department of RAdiobiology and Regenerative Medicine (SERAMED), Laboratory of Medical Radiobiology (LRMed), Fontenay-aux-Roses, 92260, France.

V Paget (V)

Institute for Radiological Protection and Nuclear Safety (IRSN), Department of RAdiobiology and Regenerative Medicine (SERAMED), Laboratory of Medical Radiobiology (LRMed), Fontenay-aux-Roses, 92260, France. vincent.paget@irsn.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH